Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome

Thrombosis and Haemostasis

Volumn 75, Issue 2, 1996, Pages 224-228

  Gando, Satoshi ^a   Kameue, Takashi ^a   Nanzaki, Satoshi ^a   Nakanishi, Yoshimi ^a  

^a SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; GABEXATE MESILATE; NAFAMSTAT MESILATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; INCIDENCE; INFLAMMATION; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC;

EID: 0029876674     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650248     Document Type: Article

References (22)

1. Marder VJ, Feinstein DI, Francis CW, Colman RW. Consumptive thrombohemorrhagic disorders. In: Hemostasis and Thrombosis. Basic principles and clinical practice, 3rd ed. Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. Philadelphia: Lippincott 1994; pp 1023-63.
2. Levi M, ten Cate H, van der Poll T, van Deventer SGH. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 975-9.
3. Gando S, Tedo I, Kubota M. Posttrauma coagulation and fibrinolysis. Crit Care Med 1992, 20: 594-600.
4. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816-23.
5. Bone RC. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med 1992; 152: 1381-9.
6. Moalli R, Doyle JM, Tahhan HR, Hasan FM, Braman SS, Saldeen T. Fibrinolysis in critically ill patients. Am Rev Respir Dis 1989; 140: 287-93.
7. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
8. Scientific and Standardization Committee Communications. Nomenclature of quantities and units in thrombosis and haemostasis (Recommendation 1993). Thromb Haemost 1994; 71: 375-94.
9. Civil ID, Scwab CW. The abbreviated injury scale, 1985; revision: A condensed chart for clinical use. J Trauma 1988; 28: 87-90.
10. Knaus WA, Draper EA, Wanger D, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-29.
11. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-3.
12. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992; 216: 117-34.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic curve. Radiology 1982; 143: 29-36.
14. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
15. Andersson TR, Berner NS, Larsen ML, Ødegaad OR, Abildgaard U. Plasma heparin cofactor II, protein C, and antithrombin in elective surgery. Acta Chir Scand 1987; 153: 291-6.
16. Francis RB, Seyfert U. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: Clinicopathologic correlations. J Lab Clin Med 1987; 110: 541-7.
17. Hesselvik JF, Blombäck M, Brodin B, Maller R. Coagulation, fibrinolysis, and kallikrein system in sepsis: Relation to outcome. Crit Care Med 1989; 17: 724-33.
18. Albert J, Blomqvist H, Gårdlund B, Jakobsson J, Svensson J, Blombäck M. Effect of antithrombin concentrate on haemostatic variables in critically ill patients. Acta Anaesthesiol Scand 1992; 36: 745-52.
19. Kruithof EKO, Guidinchet A, Bachmann F. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost 1988; 59: 7-12.
20. Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, Backmann F, Kruithof EKO. Plasminogen activator inhibitor-1: A new prognostic marker in septic shock. Thromb Haemost 1989; 61: 459-62.
21. Hellgren M, Egberg N, Eklund J. Blood coagulation and fibrinolytic factors and their inhibitors in criticially ill patients. Intensive Care Med 1984; 10: 23-8.
22. Bredbacka S, Blombäck M, Wiman B, Pelzer H. Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects. Acta Anaesthesiol Scand 1993; 37: 125-30.